Dr. Nicholas P. Slimack, MD

Dr. Slimack practices at Santa Maria Specialty Health Center in Santa Maria, California.

Dr. Slimack's NPI, 1265743884, was assigned on June 29, 2010. Dr. Slimack graduated from Loyola University Chicago Stritch School of Medicine in 2005. Dr. Slimack holds California license A120078.

Dr. Slimack's primary practice is Santa Maria Specialty Health Center, at 300 S Stratford Ave, Santa Maria, CA 93454-5903. The practice phone is (805) 739-3863.

Dr. Slimack's primary practice is Santa Maria Specialty Health Center in Santa Maria, California. Dr. Slimack is also affiliated with Dignity Health - Marian Regional Medical Center. The medical group on file is Pacific Central Coast Health Centers Medical Group. Dmand AI also links Dr. Slimack to 1 more hospital and 2 home health agencies, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Slimack practices, 5 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Slimack's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Slimack is board certified in neurological surgery by the American Board of Neurological Surgery. Dmand AI has Dr. Slimack's licenses on file in 2 states: California and Illinois.

Dmand AI lists back and neck pain treatment without fusion, craniotomy, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems, spinal fusion and thoracic spine disorders among the conditions Dr. Slimack treats.

CMS data shows 329 Medicare services from Dr. Slimack across 8 procedure codes in 2024, for 223 Medicare patients. Medicare paid $22,136 for them.

CMS counts 223 Medicare patients who saw Dr. Slimack in 2024. The largest group is 65 to 74, with 97 patients. 75% of them have arthritis, and 75% have high blood pressure. 27% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Slimack's median patient age at 64, with 52% women.

In 2024, Dr. Slimack wrote 49 Medicare Part D claims for 27 patients. 100% of them were for generic drugs. CMS names the drug for 17 of them, across 1 drug with 11 or more claims each, at $212 in total drug cost. In 2023, CMS named 48 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Slimack for performance year 2024, reported through an alternative payment model (APM). Dr. Slimack accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 78 procedures of laminectomy or laminotomy (partial removal of spine bones) by Dr. Slimack, more than 89% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Dr. Slimack, published from 2011 to 2012. 2011 was the busiest year, with 3. The most frequent topics are Prostatic Neoplasms, Patient Participation and Spinal Fusion. Dr. Slimack has published most often in Clin Prostate Cancer. Dr. Slimack's most frequent co-authors are Richard Glenn Fessler, MD, Tyler R. Koski, MD and Timothy M. Kuzel, MD.

CMS Open Payments shows 77 general payments to Dr. Slimack from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic USA, Inc. paid the most, $1,685.

Dr. Slimack graduated from Loyola University Chicago Stritch School of Medicine in 2005. Dr. Slimack is a member of CNS.

Dr. Slimack is in network with 10 carriers, including Elevance, Aetna and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.